Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma
Conclusions Switch maintenance therapy with S-1 after induction therapy with carboplatin andnab-paclitaxel was associated with moderate efficacy and acceptable safety and may represent a feasible treatment option for patients with advanced SCC.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Abraxane | Cancer & Oncology | Carcinoma | Chemotherapy | Investigational New Drugs | Nanotechnology | Oral Cancer | Skin Cancer | Squamous Cell Carcinoma | Study | Toxicology